期刊文献+

肺动脉高压药物治疗进展 被引量:2

原文传递
导出
摘要 肺动脉高压(PAH)是一类以各种肺内或肺外疾病引起的,以肺动脉压力(PAP)和肺血管阻力(PVR)进行性升高为特征,最终导致右心功能受损、甚至死亡的严重疾病。
作者 丁永杰 李敏
出处 《内科理论与实践》 2011年第6期451-458,共8页 Journal of Internal Medicine Concepts & Practice
  • 相关文献

参考文献3

二级参考文献29

  • 1荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 2Rubin LJ. Primary pulmonary hypertension. N Engl J Med, 1997, 336: 111-117.
  • 3D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary, hypertension: results from a national prospective registry. Ann Intern Med, 1991, 115 : 343-349.
  • 4Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132:373-379.
  • 5Badesch DB, Abman S H, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: up dated ACCP evidence-based clinical practice guidelines. Chest, 2007, 131:1917-1928.
  • 6McGoon M, Gutterman D, Steen V, et al. Screening, Early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest, 2004, 126: 14s-34s.
  • 7Gomez A, Bialostozky D, Zajarias A, et al. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol, 2001, 38:1137-1142.
  • 8Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.N Engl J Med, 1993, 328:1732-1739.
  • 9Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med, 2004, 351:1655-1665.
  • 10Pearl JM, Wellmann SA, McNamara JL, et al. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function. Ann Thorac Surg, 1999, 68:1714- 1721.

共引文献67

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部